Study on the mechanism of apatinib mesylate inhibiting breast cancer cell proliferation through Erk1/2 signaling pathway
LIU Xinlan
HOU Yujin
LV Yan
GUO Ting
Machine-generated Keywords：
Publication Date：2021-06-28
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：7( 481-487 )